ECSP961634A - AGONISTS, ESTROGEN ANTAGONISTS - Google Patents
AGONISTS, ESTROGEN ANTAGONISTSInfo
- Publication number
- ECSP961634A ECSP961634A ECSP961634A ECSP961634A EC SP961634 A ECSP961634 A EC SP961634A EC SP961634 A ECSP961634 A EC SP961634A EC SP961634 A ECSP961634 A EC SP961634A
- Authority
- EC
- Ecuador
- Prior art keywords
- agonists
- estrogen antagonists
- diseases
- estrogen
- antagonists
- Prior art date
Links
- 239000000556 agonist Substances 0.000 title 1
- 239000000328 estrogen antagonist Substances 0.000 title 1
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 201000009273 Endometriosis Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 208000017497 prostate disease Diseases 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Compuestos de fórmula: Utiles para el tratamiento o prevención de la obesidad, cáncer de mama, osteoporosis, endometriosis, enfermedades cardiovasculares y enfermedades prostáticas.Compounds of formula: Useful for the treatment or prevention of obesity, breast cancer, osteoporosis, endometriosis, cardiovascular diseases and prostate diseases.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP961634 ECSP961634A (en) | 1996-01-09 | 1996-01-09 | AGONISTS, ESTROGEN ANTAGONISTS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP961634 ECSP961634A (en) | 1996-01-09 | 1996-01-09 | AGONISTS, ESTROGEN ANTAGONISTS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP961634A true ECSP961634A (en) | 1997-06-11 |
Family
ID=42042368
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP961634 ECSP961634A (en) | 1996-01-09 | 1996-01-09 | AGONISTS, ESTROGEN ANTAGONISTS |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP961634A (en) |
-
1996
- 1996-01-09 EC ECSP961634 patent/ECSP961634A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU596A (en) | Estrogen agonists/antagonists | |
| HU0200264D0 (en) | Estrogen agonists/antagonists for the treatment of certain cancers | |
| DK1556058T3 (en) | Pharmaceutical compositions comprising oestetrol derivatives for use in cancer therapy | |
| SI1187632T1 (en) | TREATMENT WITH ANTI-ErbB2 ANTIBODIES | |
| EP0897726A4 (en) | Antipruritic agent | |
| ATE253039T1 (en) | BETA 2 ADRENERGIC RECEPTOR AGONISTS | |
| EP2053129A3 (en) | Method of diagnosing, monitoring, staging, imaging and treating various cancers | |
| DE69942827D1 (en) | USE OF EPOTHILONS FOR THE TREATMENT OF CANCER | |
| EP1129089A4 (en) | SPIRO-INDOLINS AS Y5 RECEPTOR ANTAGONISTS | |
| IL149402A0 (en) | Arylamine derivatives and their use as anti-telomerase agent | |
| EA200200545A1 (en) | ONCOLYTIC COMBINATIONS FOR CANCER TREATMENT | |
| IS5035A (en) | Methods for the prevention of breast cancer | |
| ZA200003236B (en) | Combination therapy for the treatment of migraine. | |
| ATE265455T1 (en) | TETRAHYDROPYRIDO COMPOUNDS | |
| DK1079851T3 (en) | Use of anti-prolactin agents for the treatment of cancer | |
| HUP0101947A3 (en) | Combination for the treatment of tumors | |
| ECSP961634A (en) | AGONISTS, ESTROGEN ANTAGONISTS | |
| ZA200108256B (en) | Compositions and methods for the treatment and diagnosis of breast cancer. | |
| ZA200002338B (en) | Combination therapy for the treatment of migraine. | |
| WO2000036144A3 (en) | Cancer diagnostic method using p40 subunit of eif3 | |
| FR2842109B1 (en) | USE OF A CHRYSANTHELLUM EXTRACT | |
| GB2379444A9 (en) | Assay for cancer of the prostate | |
| IT1314187B1 (en) | Combination of different pharmaceutical compositions, useful for treating mammary carcinoma | |
| ATE241991T1 (en) | SYNERGISTIC COMPOSITION CONTAINING DAUNORUBICIN DERIVATIVES AND ANTIMETABOLITES | |
| RU98100756A (en) | COPPER CEMENT MATERIAL |